Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Multicenter, Evaluator Blinded, Randomized Study to Evaluate the Safety and Effectiveness of HArmonyCa Lidocaine Compared to Restylane® Perlane® Lidocaine for Restoration and/or Creation of Mid-face Volume

NCT07032597 is registered in ClinicalTrials.gov with AbbVie as lead sponsor.

NCT NCT07032597
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07032597 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Multicenter, Evaluator Blinded, Randomized Study to Evaluate the Safety and Effectiveness of HArmonyCa Lidocaine Compared to Restylane® Perlane® Lidocaine for Restoration and/or Creation of Mid-face Volume
Lead sponsor
AbbVie
Phase
Phase 3
Overall status
Completed
Start date
May 26, 2025
Completion date
September 3, 2026
Enrollment
252 (actual)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

mid face volume deficit